Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 206488

Expand all

EXONDYS 51 (ETEPLIRSEN)
100MG/2ML (50MG/ML) Marketing Status: Prescription

Active Ingredient: ETEPLIRSEN
Proprietary Name: EXONDYS 51
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 100MG/2ML (50MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N206488
Product Number: 001
Approval Date: Sep 19, 2016
Applicant Holder Full Name: SAREPTA THERAPEUTICS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

EXONDYS 51 (ETEPLIRSEN)
500MG/10ML (50MG/ML) Marketing Status: Prescription

Active Ingredient: ETEPLIRSEN
Proprietary Name: EXONDYS 51
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 500MG/10ML (50MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N206488
Product Number: 002
Approval Date: Sep 19, 2016
Applicant Holder Full Name: SAREPTA THERAPEUTICS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English